rs5498 is a SNP of the ICAM1 gene. It is significantly associated with ICAM-1 measurement. It is also strongly associated with diabetic nephropathy (DN) in females with type 1 diabetes (T1D).
The minor allele ''G'' is correlated with with higher sICAM-1 (soluble Intercellular Adhesion Molecule 1) levels and has been associated with lower risk of asthma [R].
In whites, rs5498 was significantly associated with sICAM-1 (p<0.001) and each of the ''G'' allele was associated with 5% higher sICAM-1 concentration [R].
The ''A'' allele increased stepwise from non-diabetic control subjects to type 1 diabetes (T1D) patients without diabetic nephropathy and T1D patients with diabetic nephropathy. ''A'' allele confers susceptibility to the development of T1D [R].
The major allele ''A'' was increased from type 1 diabetes (T1D) patients without diabetic nephropathy (DN) to the patients with DN in females of the GoKinD population. The allele ''G'' is associated with the decreased risk susceptibility in female T1D patients with DN [R].
The ''G'' allele was significantly associated with higher levels of sICAM-1 (soluble Intercellular adhesion molecule-1) [R].
At least one ''G'' allele increases the risk of prostate cancer in men with a family history of prostate cancer (odds ratio = 1.8) [R].
The heterozygosity and positivity for the allele ''G'' were found to be significantly associated with diabetic nephropathy (DN) in female type 1 diabetes (T1D) patients (P = 0.010, OR = 0.633, and P = 0.026, OR = 0.692) [R].
A higher prevalence of ''G'' allele carriers (AG + GG) was seen in patients compared to controls (68 vs. 64%, P = 0.399). A synergistic effect of ''G'' allele carrier-state and smoking that had influenced the risk of CAD was observed. Smoking carriers of ''G'' allele compared to non-smoking ''AA'' were more prevalent in CAD group (39.8%) than among controls (13.3%, P < 0.0001, OR 4.81). Moreover, there was also a synergistic effect between ''G'' allele carrier-state and an elevated level of triacylglycerols (TG) (SIM = 1.28) increasing the risk of CAD [R].
The ''G'' allele was associated with increased risk of severe malaria (OR = 1.91; P = 0.02) [R].
The ''G'' allele was associated with increased tumor grade (OR=2.650) and epithelial ovarian cancer (EOC) risk (OR=1.405). However, the ''G'' allele correlated with EOC survival time in patients whose first-degree relatives (FDRs) suffered from a tumor (p=0.001) [R].
Individuals with the ''G'' allele had a higher risk for oral squamous cell carcinoma (OSCC) [R].
The ''A'' allele along with the ''G'' allele of rs1799969 may be protective against brain tumors [R].
The ''A'' is a putative risk predisposing allele for T2D retinopathy and its clinical covariates in Indian population.The AA genotype was seen at a higher frequency in the retinopathy group (p=0.012). The risk for diabetic retinopathy (DR) increased in the presence of AA genotype (OR=1.89-4.82) [R].
A decreased frequency of the ''AA'' genotype was observed in the peripheral artery disease (PAD) subjects compared to controls (p=0.06) [R].
The risk of asthma was higher for children carrying the GG genotype (odds ratio = 1.68) than for those with the AA or AG genotypes [R].
A/G genotypes were significantly associated with diabetic nephropathy (DN) [R].
Genotype ''AG'' and ''GG'' were associated with hepatocellular carcinoma (HCC) risk among smokers [R].
The ''GG'' genotype was associated with a higher risk of invasive cancer and precancerous lesions, respectively, but with lower power [R].
A>G polymorphism was associated with a significantly increased risk of oral cancer, but with protection from colorectal cancer and melanoma [R].